NCT03548337 - Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In India | Biotech Hunter

Enrollment

301

Participants

Timeline

Start Date

May 31, 2018

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions

Vaccines

Interventions

BIOLOGICAL

13vPnC

13vPnC MultiDose Vial with preservative compared to a Prefilled syringe containing 13vPnC without any preservative

Trial Locations (7)

Sir Ganga Ram Hospital, New Delhi

B. J. Medical College & Civil Hospital, Ahmedabad

Bharati Vidyapeeth University Medical College, Pune

Manipal Hospital, Bengaluru

Kanchi Kamakoti Childs Trust Hospital, Chennai, Tamil Nadu

Sri Ramachandra Hospital, Chennai

KEM Hospital Research Centre, Pune